103 related articles for article (PubMed ID: 12773894)
1. [Neuroprotection and neurodegenerative parkinsonian syndromes].
Destée A
Rev Neurol (Paris); 2003 May; 159(5 Pt 2):3S93-104. PubMed ID: 12773894
[TBL] [Abstract][Full Text] [Related]
2. Degeneration in different parkinsonian syndromes relates to astrocyte type and astrocyte protein expression.
Song YJ; Halliday GM; Holton JL; Lashley T; O'Sullivan SS; McCann H; Lees AJ; Ozawa T; Williams DR; Lockhart PJ; Revesz TR
J Neuropathol Exp Neurol; 2009 Oct; 68(10):1073-83. PubMed ID: 19918119
[TBL] [Abstract][Full Text] [Related]
3. [Contribution of oculomotor examination for the etiological diagnosis of parkinsonian syndromes].
Pierrot-Deseilligny Ch; Rivaud-Péchoux S
Rev Neurol (Paris); 2003 May; 159(5 Pt 2):3S75-81. PubMed ID: 12773891
[TBL] [Abstract][Full Text] [Related]
4. Progressive supranuclear palsy and corticobasal degeneration: lumping versus splitting.
Scaravilli T; Tolosa E; Ferrer I
Mov Disord; 2005 Aug; 20 Suppl 12():S21-8. PubMed ID: 16092076
[TBL] [Abstract][Full Text] [Related]
5. Measurements of transcallosally mediated cortical inhibition for differentiating parkinsonian syndromes.
Wolters A; Classen J; Kunesch E; Grossmann A; Benecke R
Mov Disord; 2004 May; 19(5):518-28. PubMed ID: 15133815
[TBL] [Abstract][Full Text] [Related]
6. Parkinson's disease. Diagnosis and the initiation of therapy.
Bhat V; Weiner WJ
Minerva Med; 2005 Jun; 96(3):145-54. PubMed ID: 16175158
[TBL] [Abstract][Full Text] [Related]
7. MRI for the differential diagnosis of neurodegenerative parkinsonism in clinical practice.
Seppi K
Parkinsonism Relat Disord; 2007; 13 Suppl 3():S400-5. PubMed ID: 18267272
[TBL] [Abstract][Full Text] [Related]
8. Magnetic resonance imaging-based volumetry differentiates progressive supranuclear palsy from corticobasal degeneration.
Gröschel K; Hauser TK; Luft A; Patronas N; Dichgans J; Litvan I; Schulz JB
Neuroimage; 2004 Feb; 21(2):714-24. PubMed ID: 14980574
[TBL] [Abstract][Full Text] [Related]
9. Levodopa responsiveness in disorders with parkinsonism: a review of the literature.
Constantinescu R; Richard I; Kurlan R
Mov Disord; 2007 Nov; 22(15):2141-8; quiz 2295. PubMed ID: 17534959
[TBL] [Abstract][Full Text] [Related]
10. Parkinson's syndrome associated with neurofibrillary degeneration and tau pathologic findings.
Lees AJ
Mov Disord; 2003 Sep; 18 Suppl 6():S28-33. PubMed ID: 14502653
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP.
Josephs KA; Petersen RC; Knopman DS; Boeve BF; Whitwell JL; Duffy JR; Parisi JE; Dickson DW
Neurology; 2006 Jan; 66(1):41-8. PubMed ID: 16401843
[TBL] [Abstract][Full Text] [Related]
12. L-deprenyl protects against rotenone-induced, oxidative stress-mediated dopaminergic neurodegeneration in rats.
Saravanan KS; Sindhu KM; Senthilkumar KS; Mohanakumar KP
Neurochem Int; 2006 Jul; 49(1):28-40. PubMed ID: 16490285
[TBL] [Abstract][Full Text] [Related]
13. PET measurement of cardiac and nigrostriatal denervation in Parkinsonian syndromes.
Raffel DM; Koeppe RA; Little R; Wang CN; Liu S; Junck L; Heumann M; Gilman S
J Nucl Med; 2006 Nov; 47(11):1769-77. PubMed ID: 17079809
[TBL] [Abstract][Full Text] [Related]
14. Parkinsonism plus syndrome--a review.
Mitra K; Gangopadhaya PK; Das SK
Neurol India; 2003 Jun; 51(2):183-8. PubMed ID: 14570999
[TBL] [Abstract][Full Text] [Related]
15. [Corticobasal degeneration and atypical progressive supranuclear palsy: their symptomatology, laboratory examination and differential diagnosis].
Morimatsu M; Negoro K; Mori H
Rinsho Shinkeigaku; 2004 Nov; 44(11):982-5. PubMed ID: 15651349
[TBL] [Abstract][Full Text] [Related]
16. Applause sign in Parkinsonian disorders and Huntington's disease.
Wu LJ; Sitburana O; Davidson A; Jankovic J
Mov Disord; 2008 Dec; 23(16):2307-11. PubMed ID: 18972544
[TBL] [Abstract][Full Text] [Related]
17. Neurofilament heavy-chain NfH(SMI35) in cerebrospinal fluid supports the differential diagnosis of Parkinsonian syndromes.
Brettschneider J; Petzold A; Süssmuth SD; Landwehrmeyer GB; Ludolph AC; Kassubek J; Tumani H
Mov Disord; 2006 Dec; 21(12):2224-7. PubMed ID: 17013909
[TBL] [Abstract][Full Text] [Related]
18. Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
Chaturvedi RK; Shukla S; Seth K; Chauhan S; Sinha C; Shukla Y; Agrawal AK
Neurobiol Dis; 2006 May; 22(2):421-34. PubMed ID: 16480889
[TBL] [Abstract][Full Text] [Related]
19. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
[TBL] [Abstract][Full Text] [Related]
20. [A 65-year-old man with rigid-bradykinetic parkinsonism, vertical gaze palsy, difficulty of eye-lid opening, and marked pseudo-bulbar palsy].
Noda K; Kobayashi T; Matsuoka S; Takanashi M; Kanazawa A; Mizuno Y
No To Shinkei; 2005 Jan; 57(1):73-86. PubMed ID: 15782604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
